Anumana announced today that it brought its diagnostic ECG-AI technology into perioperative and acute cardiac care with help from Boston Scientific.
Anumana expands AI cardiac care platform with support from Boston Scientific
Related Articles
AI-guided Detection of Heart Disease in Routine Practice
Med India: Artificial intelligence (AI) screening helps detect low ejection fraction using data from an EKG could improve the diagnosis of this condition in routine practice. Study findings are published…{post_date: F d, Y}
New Study Demonstrates Value of AI-Enabled EKG Algorithm in Routine Practice
AZO Robotics: The EAGLE—short for ECG AI-Guided Screening for Low Ejection Fraction—trial attempted to establish whether an artificial intelligence (AI) screening tool designed to spot low ejection fraction through EKG…{post_date: F d, Y}
Anumana to Share Latest Advances in ECG-AI at AHA Scientific Sessions 2025
Company to present four studies, including a late-breaking featured science presentation, and host interactive experiences demonstrating AI’s role in cardiovascular care{post_date: F d, Y}
StartUp Health Insights: Virta & 1Doc3 Close Rounds, Over $1.4B Raised This Week
Health Transformer: Anumana, a startup designing neural network algorithms to enable early detection and accelerate treatment of heart disease, raised $25.7M led by founders nference and Mayo Clinic, with participation…{post_date: F d, Y}